In summary, our findings in preclinical models of inherited retinal degeneration show that antagonizing the cytokine signaling inhibitor SOCS3 can potentiate endogenous neuroprotective capacities and effectively prolong neuron survival without compromising visual function. Here, SOCS3 is linked to retinal degeneration.